Purification and Partial Characterization of Draculin, the Anticoagulant Factor Present in the Saliva of Vampire Bats (Desmodus rotundus)

Summary

From the saliva of the vampire bat Desmodus rotundus, we isolated an unknown anticoagulant protein which we have named draculin. Its molecular mass as determined by non-reduced SDS-PAGE is about 83 kDa. The reduced polypeptide shows a slower migration. HPLC in a molecular sieve matrix yields a single, symmetrical peak corresponding to 88.5 kDa. Isoelectric focusing shows an acidic protein with pI = 4.1–4.2. Aminoacid analysis is compatible with a single chain polypeptide of about 80 kDa. Cyanogen bromide cleavage yields a single 16-aminoacid peptide, corresponding to the amino-terminus of the native molecule. Draculin inhibits the activated form of coagulation factors IX and X. It does not act on thrombin, trypsin, chymotrypsin and does not express fibrinolytic activity. The inhibition is immediate and not readily reversible, with a stoichiometry of about two molecules of draculin per molecule of factor IXa or Xa. Surprisingly, the inhibitory activity against either factor is not affected by the presence of the other. Draculin binds quantitatively to either immobilised factor Xa or factor IXa. Our preliminary interpretation is that there are two forms of draculin that hardly differ in structure. Both bind to factor Xa and to factor IXa but one form inhibits factor Xa and the other inhibits factor IXa.

When added to plasma, draculin increases the lag phase as well as the height of the peak of thrombin generation.

• References

• 1 Bier OG. Action anticoagulante et fibrinolytique de l’extrait des glandes salivaires d’une chauve-souris hématophage (Desmodus rufus). Comptes Rendus Soc Biol (Paris) 1932; 110: 129-131
• 2 Romana C. Action anticoagulante de la salive du vampire (Desmodus rotundus). Soc Pathol Exot 1939; 32: 399-403
• 3 Gardell SJ, Duong LT, Diehl RE, York JD, Hare TR, Register RB, Jacobs JW, Dixon RA F, Friedman PA. Isolation, characterization, and cDNA cloning of a vampire bat salivary plasminogen activator. J Biol Chem 1989; 264: 17947-17952
• 4 Hawkey C. Plasminogen activator in saliva of the vampire bat Desmodus rotundus. Nature 1966; 211: 434-435
• 5 Cartwright T. The plasminogen activator of vampire bat saliva. Blood 1974; 43: 318-326
• 6 Dickson JM, Green DG. The vampire bat (Desmodus rotundus): Improved methods of laboratory care. Laboratory Animals 1970; 4: 37-44
• 7 Jameson GW, Roberts DV, Adams RW, Kyle WS A, Elmore DT. Thiobenzyl benzylocarbonyl-L-lisinate. Substrate for a sensitive assay for trypsinlike enzymes Biochem J 1973; 131: 107-117
• 8 Van Diejen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 1981; 256: 3433-3442
• 9 Wagenvoord R, Hendrix H, Trans T, Hemker HC. Development of a rapid and sensitive factor IX assay for clinical use. Haemostasis 1990; 20: 276-288
• 10 Green DJ, Shaw E. Thiobenzyl Benzyloxycarbonyl-L-lysinate, a substrate for a sensitive colorimetric assay for Trypsin-like enzymes. Anal Biochem 1979; 93: 223-226
• 11 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
• 12 Shagger H, von Jagow G. Tricine-Sodium Dedecyl Sulfate-Polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDaz. Anal Biochem 1987; 166: 368-379
• 13 Fairbanks G, Stack TL, Wallack DF H. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 1971; 10: 2617-2642
• 14 Vesterberg O, Gramstrump-Christensen B. Sensitive silver staining of proteins after isoelectric focusing in agarose gels. Electrophoresis 1984; 5: 282-285
• 15 Hemker HC, Willems GM, Béguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986; 56: 9-17
• 16 Béguin S, Kessels H, Dol F, Hemker HC. The consumption of antithrombin III during coagulation, its consequences for the calculation of pro- thrombinase activity and the standardisation of heparin activity. Thromb Haemost 1992; 68: 136-142
• 17 Béguin S, Dol F, Hemker HC. Factor IXa inhibition contributes to the heparin effect. Thromb Haemost 1991; 66: 306-309
• 18 Tuszynski GP, Gasic TB, Gasic GJ. Isolation and characterization of Anti- stasin. J Biol Chem 1987; 262: 9718-9723
• 19 Waxman L, Smith DE, Arcuri KE, Vlasuk GP. Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science 1990; 248: 593-596
• 20 Jacobs JW, Crupp EW, Sardana M, Friedman PA. Isolation and characterization of a coagulation factor Xa inhibitor from black fly salivary glands. Thromb Haemostas 1990; 64: 235-238
• 21 Brankamp RG, Blankenship DT, Sunkara PS, Cardin AD. Ghilantens. Anticoagulant-antimetastatic proteins from the South American leech, Haementeria ghilianii J Lab Clin Med 1990; 115: 89-97
• 22 Hellman K, Hawkins RI. The action of tick extracts on blood coagulation and fibrinolysis. Thrombosis Diath Haemorrh 1967; 18: 617-625
• 23 Seymur JL, Lindquist RN, Dennis MS, Moffat B, Yansura D, Reilly D, Wessinger ME, Lazarus RA. Ecotin is a potent anticoagulant and reversible tight-binding inhibitor of factor Xa. Biochemistry 1994; 33: 3949-3958